{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T23:34:43Z","timestamp":1773531283009,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.pdpdt.2021.102449","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T10:57:41Z","timestamp":1627124261000},"page":"102449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown"],"prefix":"10.1016","volume":"35","author":[{"given":"Muhammed Nurullah","family":"Bulut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice Selen","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gizem","family":"G\u00f6k\u00e7e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u0131l","family":"A\u011fa\u00e7kesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezban","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aynur","family":"Hac\u0131saliho\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysu","family":"Arsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eaban","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pdpdt.2021.102449_bib0001","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ophtha.2018.07.028","article-title":"Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration: a Report by the American Academy of Ophthalmology","volume":"126","author":"Bakri","year":"2019","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.pdpdt.2021.102449_bib0002","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2020.03.021","article-title":"Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)","volume":"127","author":"Glassman","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.pdpdt.2021.102449_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000502041","article-title":"Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)","volume":"242","author":"Schmidt-Erfurth","year":"2019","journal-title":"Ophthalmologica"},{"issue":"12","key":"10.1016\/j.pdpdt.2021.102449_bib0004","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Schmidt-Erfurth U; VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102449_bib0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","article-title":"Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies","volume":"121","author":"Schmidt-Erfurth","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2021.102449_bib0006","unstructured":"American Academy of Ophthalmology (2020) Important coronavirus updates for ophthalmologists. https:\/\/www.aao.org\/headline\/alert-important-coronavirus-context. Accessed March 31, 2020."},{"key":"10.1016\/j.pdpdt.2021.102449_bib0007","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise d'Ophtalmologie (2020) Quelle Conduite \u00e0 Tenir Adopter Vis \u00e0 Vis Des Injections Intravitr\u00e9ennes (IVT) Dans Cette P\u00e9riode D\u2019\u00e9pid\u00e9mie Au Covid-19 - SARS-CoV-2 ? https:\/\/www.sfo.asso.fr\/files\/files\/FPHUNG\/epidemie_au_covid-19_-_ivt.pdf. Accessed March 31, 2020."},{"key":"10.1016\/j.pdpdt.2021.102449_bib0008","unstructured":"Deutsche Opthalmologische Gesellschaft (2020) Coronavirus COVID-19. https:\/\/www.dog.org\/?cat=288. Accessed March 31, 2020."},{"key":"10.1016\/j.pdpdt.2021.102449_bib0009","unstructured":"The Royal College of Ophthalmologists (2020) Medical retinal management plans during COVID-19. https:\/\/www.rcophth.ac.uk\/wpcontent\/uploads\/2020\/03\/Medical-Retinal-Management-Plan-during- COVID-19-UPDATED-300320-1-2.pdf. Accessed 29 Apr 2020."},{"key":"10.1016\/j.pdpdt.2021.102449_bib0010","unstructured":"Japanese Ophthalmological Society (2020) Guidance for ophthalmology-related healthcare workers regarding COVID-19. http:\/\/www.nichigan.or.jp\/news\/065.pdf.AccessedMarch 31, 2020."},{"issue":"4","key":"10.1016\/j.pdpdt.2021.102449_bib0011","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.pdpdt.2021.102449_bib0012","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.ophtha.2015.08.006","article-title":"Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials","volume":"122","author":"Boyer","year":"2015","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.pdpdt.2021.102449_bib0013","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","article-title":"Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and. RIDE","volume":"120","author":"Brown","year":"2013","journal-title":"OphthalmologyOphthalmology"},{"key":"10.1016\/j.pdpdt.2021.102449_bib0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajo.2020.06.040","article-title":"The Short-term Effect of a Single Lapse in Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema Within Routine Clinical Practice","volume":"219","author":"Yalamanchili","year":"2020","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.pdpdt.2021.102449_bib0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/IAE.0000000000000336","article-title":"Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy","volume":"35","author":"De Benedetto","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2021.102449_bib0016","article-title":"Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China","volume":"7","author":"Yang","year":"2020","journal-title":"Front Med. (Lausanne)"},{"issue":"12","key":"10.1016\/j.pdpdt.2021.102449_bib0017","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00417-020-04849-8","article-title":"Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19","volume":"258","author":"Stone","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2021.102449_bib0018","first-page":"1","article-title":"Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity","author":"Stone","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"3","key":"10.1016\/j.pdpdt.2021.102449_bib0019","first-page":"1","article-title":"Effect of COVID-19 Pandemic on Anti-VEGF Treatment of Medical Retinal Conditions","volume":"6","author":"Rahimzadeh","year":"2021","journal-title":"The Physician"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021002738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021002738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:39:26Z","timestamp":1761611966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100021002738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":19,"alternative-id":["S1572100021002738"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102449","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102449"}}